Literature DB >> 24338593

Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Veronica H Flood1.   

Abstract

Diagnosis of von Willebrand disease (VWD) merits consideration of personal and family history of bleeding symptoms along with confirmatory laboratory testing. As the latter yields quantifiable results, overreliance on a laboratory diagnosis may occur. However, existing tests for VWD contain potential sources for error. Both intrinsic and extrinsic factors affecting these assays can contribute to either falsely normal or falsely abnormal results. This article will discuss the present available assays as well as new developments in diagnostic testing. A clear understanding of the limitations of VWD testing is helpful for ensuring the correct diagnosis of affected patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 24338593      PMCID: PMC3987108          DOI: 10.1055/s-0033-1363166

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  79 in total

1.  VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Authors:  Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Amy D Shapiro; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Jeanne M Lusher; Margaret V Ragni; Robert R Montgomery
Journal:  Blood       Date:  2011-12-23       Impact factor: 22.113

2.  Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.

Authors:  V H Flood; J C Gill; P A Christopherson; J S Wren; K D Friedman; S L Haberichter; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

3.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors:  V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

Review 4.  Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.

Authors:  Emmanuel J Favaloro
Journal:  Blood Coagul Fibrinolysis       Date:  2011-10       Impact factor: 1.276

5.  Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay.

Authors:  D Chen; J I Tange; B J Meyers; R K Pruthi; W L Nichols; J A Heit
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

6.  A novel flow cytometry single tube bead assay for quantitation of von Willebrand factor antigen and collagen-binding.

Authors:  Ashraf Mina; Emmanuel J Favaloro; Jerry Koutts
Journal:  Thromb Haemost       Date:  2012-09-26       Impact factor: 5.249

7.  Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.

Authors:  E J Favaloro; R Bonar; K Chapman; M Meiring; D Funk Adcock
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

8.  No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

Authors:  Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Pamela A Christopherson; Brian R Branchford; Raymond G Hoffmann; Thomas C Abshire; Amy L Dunn; Jorge A Di Paola; W Keith Hoots; Deborah L Brown; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

9.  A comparative evaluation of a new automated assay for von Willebrand factor activity.

Authors:  A S Lawrie; F Stufano; M T Canciani; I J Mackie; S J Machin; F Peyvandi
Journal:  Haemophilia       Date:  2012-12-04       Impact factor: 4.287

10.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

View more
  9 in total

1.  Our findings differ.

Authors:  Bartosz Hudzik; Krzysztof Wilczek; Mariusz Gasior
Journal:  CMAJ       Date:  2015-10-20       Impact factor: 8.262

2.  Rapid discrimination of the phenotypic variants of von Willebrand disease.

Authors:  Jonathan C Roberts; Patti A Morateck; Pamela A Christopherson; Ke Yan; Raymond G Hoffmann; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2016-02-25       Impact factor: 22.113

3.  Heyde syndrome: gastrointestinal bleeding and aortic stenosis.

Authors:  Bartosz Hudzik; Krzysztof Wilczek; Mariusz Gasior
Journal:  CMAJ       Date:  2015-06-29       Impact factor: 8.262

Review 4.  Towards personalised therapy for von Willebrand disease: a future role for recombinant products.

Authors:  Emmanuel J Favaloro
Journal:  Blood Transfus       Date:  2016-03-22       Impact factor: 3.443

5.  Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers.

Authors:  Marika Pikta; Galina Zemtsovskaja; Hector Bautista; Georges Nouadje; Timea Szanto; Margus Viigimaa; Valdas Banys
Journal:  J Clin Lab Anal       Date:  2018-02-17       Impact factor: 2.352

6.  Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Authors:  Almudena Pérez-Rodríguez; Javier Batlle; Irene Corrales; Nina Borràs; Ángela Rodríguez-Trillo; Esther Lourés; Ana Rosa Cid; Santiago Bonanad; Noelia Cabrera; Andrés Moret; Rafael Parra; María Eva Mingot-Castellano; Nira Navarro; Carmen Altisent; Rocío Pérez-Montes; Shally Marcellini; Ana Moreto; Sonia Herrero; Inmaculada Soto; Nuria Fernández Mosteirín; Víctor Jiménez-Yuste; Nieves Alonso; Aurora de Andrés Jacob; Emilia Fontanes; Rosa Campos; María José Paloma; Nuria Bermejo; Rubén Berrueco; José Mateo; Karmele Arribalzaga; Pascual Marco; Ángeles Palomo; Nerea Castro Quismondo; Belén Iñigo; María Del Mar Nieto; Rosa Vidal; María Paz Martínez; Reyes Aguinaco; Maria Tenorio; María Ferreiro; Javier García-Frade; Ana María Rodríguez-Huerta; Jorge Cuesta; Ramón Rodríguez-González; Faustino García-Candel; Manuela Dobón; Carlos Aguilar; Fernando Batlle; Francisco Vidal; María Fernanda López-Fernández
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

7.  Platelet Aggregation Assays Do Not Reliably Diagnose Platelet Delta Granule Storage Pool Deficiency.

Authors:  William T Gunning; Lorene Yoxtheimer; Mary R Smith
Journal:  J Hematol       Date:  2021-07-28

Review 8.  Von Willebrand factor in patients on mechanical circulatory support - a double-edged sword between bleeding and thrombosis.

Authors:  Bartosz Hudzik; Jacek Kaczmarski; Jerzy Pacholewicz; Michal Zakliczynski; Mariusz Gasior; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-09-28

9.  Increased von Willebrand factor parameters in children with febrile seizures.

Authors:  Astrid Pechmann; Sven Wellmann; Benjamin Stoecklin; Marcus Krüger; Barbara Zieger
Journal:  PLoS One       Date:  2019-01-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.